![Goodfellow Unit artwork](https://is5-ssl.mzstatic.com/image/thumb/Podcasts123/v4/0b/3c/61/0b3c61df-d788-d023-d308-b81b8a4a6339/mza_2485450879555910194.png/100x100bb.jpg)
Alprazolam and benzodiazepine prescribing - Rob Shieff
Goodfellow Unit
English - April 16, 2017 12:00 - 18 minutesScience Health & Fitness Medicine goodfellow unit primary health care professional practitioner new zealand general Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Non-pharmacological management of COPD - Fiona Horwood
Next Episode: Vertigo - Melanie Collins
Rob Shieff talks about the removal of alprazolam (Xanax) from the New Zealand pharmaceutical schedule and issues around benzodiazepine prescribing. Rob is a general adult psychiatrist practising in Auckland. His special interest is in the evaluation and management of anxiety and mood disorders. Rob has considerable experience in psycho-pharmacology and in delivering evidence based forms of psychotherapy.